Native E. coli asparaginase upfront should be replaced by PEGasparaginase upfront in the treatment of pediatric patients with acute lymphoblastic leukemia

The peer review history for this article is available at https://publons.com/publon/10.1002/hon.2960. The data that support the findings of this letter to the editor are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions.